← Back
$TARS All transactions

Tarsus Pharmaceuticals, Inc.

▼ SELL

$ Value

$41K

Shares

1,006

Price

$41

Filed

Jun 17

Insider

Name

Lin Elizabeth Yeu

Title

Chief Medical Officer

CIK

0001842190

Roles

Officer

Transaction Details

Transaction Date

2025-06-16

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

7,694

Footnotes

The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. | The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. | Each RSU represents a contingent right to receive one share of the Company's common stock. | RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Filing Info

Accession No.

0001819790-25-000097

Form Type

4

Issuer CIK

0001819790

Lin Elizabeth Yeu's History

Date Ticker Type Value
2025-12-16 TARS $165K
2025-12-15 TARS M
2025-12-15 TARS M $0
2025-06-18 STAA A $0
2025-06-18 STAA A $0
2025-06-16 TARS $41K
2025-06-13 TARS M
2025-06-13 TARS M $0

Other Insiders at TARS (90d)

Insider Bought Sold Last
Neervannan Seshadri
Chief Operating Officer
$200K 2026-03-20